Anixa Biosciences Inc — Form 10-Q
Filed September 9, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Anixa Biosciences filed a 10-Q for the quarter ending July 31, 2026 on September 9, 2026. The filing document index and metadata are present, but the actual financial statements, narrative discussion of operations, results, risks, and material developments are not included in the text provided. No specific financial figures, counterparties, transactions, or operational changes can be identified.
Why this rating
Routine quarterly filing with no accessible substantive content to evaluate material changes or business impact relative to $85M market cap.
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.